Orally administration of 50 mg ipragliflozin once a day, pre or post breakfast for 12 weeks
Sponsors
Kato clinic of Internal medicine, Association of medical corporation Toyukai, Yutenji Medical Clinic
Conditions
Type 2 diabetes
Unknown Phase
A study on the efficacy and safety of ipragliflozin monotherapy or combination therapy under clinical use condition: continuous glucose monitoring and self monitoring of urine glucose
Active, not recruitingJPRN-UMIN000014388
Start: 2014-06-27Target: 30Updated: 2026-06-29
Investigation of the efficacy and safety of ipragliflozin in obese patients with type 2 diabetes undergoing metformin (Met)
Active, not recruitingJPRN-UMIN000014638
Start: 2014-07-25Target: 35Updated: 2026-06-29